252
Participants
Start Date
May 20, 2025
Primary Completion Date
March 28, 2027
Study Completion Date
August 15, 2027
PF-07275315
subcutaneous injection
Placebo
subcutaneous injection
NOT_YET_RECRUITING
Clinical Research of Rock Hill, Rock Hill
NOT_YET_RECRUITING
Velocity Clinical Research, Mobile, Mobile
NOT_YET_RECRUITING
Premier Research Center, LLC, Hendersonville
NOT_YET_RECRUITING
OK Clinical Research, Edmond
RECRUITING
Allergy, Asthma and Clinical Research, Oklahoma City
NOT_YET_RECRUITING
Alina Clinical Trials, LLC., Dallas
RECRUITING
Greater Heights & Memorial Pulmonary and Sleep, Houston
RECRUITING
Antelope Valley Clinical Trials, Lancaster
RECRUITING
Allergy & Asthma Clinical Research, Walnut Creek
RECRUITING
Allergy and Asthma Associates of Santa Clara Valley Research Center, San Jose
NOT_YET_RECRUITING
Shanghai General Hospital, Shanghai
NOT_YET_RECRUITING
The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou
NOT_YET_RECRUITING
Circuit Clinical / Impact Medical Allergy, Asthma & Immunology, Riverdale
NOT_YET_RECRUITING
National Hospital Organization Osaka Minami Medical Center, Kawachi-Nagano
NOT_YET_RECRUITING
NHO Kinki Chuo Chest Medical Center, Sakai
NOT_YET_RECRUITING
Fukuwa Clinic, Chuo-ku
Lead Sponsor
Pfizer
INDUSTRY